Downregulation of xIAP expression by small interfering RNA inhibits cellular viability and increases chemosensitivity to methotrexate in human hepatoma cell line HepG2

Journal of Chemotherapy

Volumn 18, Issue 5, 2006, Pages 525-531

  Chen, Jun ^a,b   Xiao, Xin Qiang ^a   Deng, Chun Ming ^a   Su, Xian Shi ^a   Li, Gui Yuan ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Chemotherapy; Hepatocellular carcinoma; siRNAs; xIAP

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; INHIBITOR OF APOPTOSIS PROTEIN; LIPOCORTIN 5; MESSENGER RNA; METHOTREXATE; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CELL STRAIN HEPG2; CELL VIABILITY; CHEMOSENSITIVITY; CONTROLLED STUDY; DOWN REGULATION; EXPRESSION VECTOR; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PLASMID; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WESTERN BLOTTING;

EID: 33751161420     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2006.18.5.525     Document Type: Article

References (28)

1. Colombo M. Hepatocellular carcinoma. J Hepatol 1992; 15(1-2): 225-36.
2. Yu-Chih Liang, Chih-Hsiung Wu, Jan-Show Chu, et al. Involvement of fatty acid-CoA ligase 4 in hepatocellular carcinoma growth: Roles of cyclic AMP and p38 mitogen-activated protein kinase World J Gastroenterol 2005;11(17):2557-63.
3. Burstein E, Ganesh L, Dick RD, et al. A novel role for XIAP in copper homeostasis through regulation of MURR1, EMBO J 2004; 23(1): 244-54.
4. Han C. Dan, Mei Sun, Satoshi Kaneko, et al. Akt phosphorylation and stabilization of x-linked inhibitor of apoptosis protein (XIAP). J Biol Chem 2004; 279(7), 5405-12.
5. Shiraki K, Sugimoto K, Yamanaka Y, et al. Overexpression of X-linked inhibitor of apoptosis in human hepatocellular carcinoma. Int J Mol Med. 2003;12(5):705-8.
6. Pei Z, Chu L, Zou W, Zhang Z, et al. An oncolytic adenoviral vector of Smac increases antitumor activity of TRAIL against HCC in human cells and in mice. Hepatology, 2004;39(5):1371-81.
7. Couzin J. Breakthrough of the year: small RNAs make big splash. Science 2002;298 (5602):2296-97.
8. Tong AW, Zhang YA, Nemunaitis J. Small interfering RNA for experimental cancer therapy. Curr Opin Mol Ther 2005;7(2):114-24.
9. Sasaki H, Sheng Y, Kotsuji F, Tsang BK. Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells. Cancer Res 2000;60 (20):5659-66.
10. Cao C, Mu Y, Hallahan DE, Lu B. XIAP and survivin as therapeutic targets for radiation sensitization in preclinical models of lung cancer. Oncogene 2004;23 (42):7047-52.
11. Lima RT, Martins LM, Guimaranes JE, Sambade C, Vasconcelos MH. Specific downregulation of bcl-2 and xIAP by RNAi enhances the effects of chemotherapeutic agents in MCF-7 human breast cancer cells. Cancer Gene Therapy 2004; 11 (5): 309-16.
12. Kashkar H, Haefs C, Shin H, et al. XIAP-mediated caspase inhibition in Hodgkin's lymphoma-derived B cells. J Exp Med. 2003;198 (2):341-47.
13. Nakagawa Y, Hasegawa M, Kurata M, et al. Expression of IAP-family proteins in adult acute mixed lineage leukemia (AMLL). Am J Hematol 2005;78 (3):173-80.
14. Byun DS, Cho K, Ryu BK, et al. Hypermethylation of XIAP-associated factor I, a putative tumor suppressor gene from the 17p13.2 locus, in human gastric adenocarcinomas. Cancer Res. 2003; 63 (21):7068-75.
15. Notarbartolo M, Cervello M, Giannitrapani L, et al. Expression of IAPs and alternative splice variants in hepatocellular carcinoma tissues and cells. Ann NY Acad Sci 2004; 1028: 289-93.
16. Riedl SJ, Renatus M, Schwarzenbacher R, et al. Structural basis for the inhibition of caspase-3 by XIAP. Cell 2001;104 (5):791-800,
17. Srinivasula SM, Hegde R, Saleh A, et al. A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis. Nature 2001;410 (6824):112-16.
18. Poland J, Wandschneider S, Urbani A, Bernardini S, Federici G, Sinha P. Use of proteomics to study chemosensitivity. Methods Mol Med 2005;111:267-81.
19. Khimani AH, Mhashilkar AM, Mikulskis A, et al. Housekeeping genes in cancer: normalization of array data. Biotechniques 2005;38(5):739-45.
20. Shin YK, Yoo BC, Chang HJ, et al. Down-regulation of mitochondrial F1F0-ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance. Cancer Res 2005;65(8):3162-70.
21. Mukhopadhyay UK, Senderowicz AM, Ferbeyre G. RNA silencing of checkpoint regulators sensitizes p53-defective prostate cancer cells to chemotherapy while sparing normal cells. Cancer Res 2005;65(7):2872-81.
22. Rouzier R, Rajan R, Wagner P, et al. Microtubule-associated protein, a marker of paclitaxel sensitivity in breast cancer. Proc Natl Acad Sci USA. 2005; 102(23):8315-20.
23. Hede K. Blocking cancer with RNA interference moves toward the clinic. J Natl Cancer Inst 2005;97(9):626-8.
24. Zhang T, Guan M, Jin HY, Lu Y. Reversal of multidrug resistance by small interfering double-stranded RNAs in ovarian cancer cells. Gynecol Oncol. 2005;97(2):501-7.
25. Brooks AD, Sayers TJ. Reduction of the antiapoptotic protein cFLIP enhances the susceptibility of human renal cancer cells to TRAIL apoptosis. Cancer Immunol Immunother. 2005;54(5):499-505.
26. Scherr M, Battmer K, Winkler T, Heidenreich O, Ganser A, Eder M. Specific inhibition of bcr-abl gene expression by small interfering RNA. Blood 2003;101(4):1566-69.
27. Nieth C, Priebsch A, Stege A, Lage H. Modulation of the classical multidrug resistance (MDR) phenotype by RNA interference (RNAi). FEBS Lett 2003;545(5):144-150.
28. Yamaguchi Y, Shiraki K, Fuke H, et al. Targeting of X-linked inhibitor of apoptosis protein or survivin by short interfering RNAs sensitize hepatoma cells to TNF-related apoptosis-inducing ligand- and chemotherapeutic agent-induced cell death. Oncol Rep 2005; 14(5):1311-1316.